In the previous World Health Organization (WHO) classification of Head and Neck Tumors (4th edition), synaptophysin (SYP), chromogranin A (CgA), and CD56 have been recommended as immunohistochemical markers of neuroendocrine differentiation [11]. Here, NCAM1 is linked to head and neck neoplasm.